Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Common Stock | Options Exercise | $0 | +11K | +42.59% | $0.00 | 36.8K | Feb 18, 2025 | Direct | F1 |
transaction | HIG | Common Stock | Options Exercise | $299K | +6.86K | +18.64% | $43.59 | 43.7K | Feb 18, 2025 | Direct | |
transaction | HIG | Common Stock | Options Exercise | $329K | +6.73K | +15.41% | $48.89 | 50.4K | Feb 18, 2025 | Direct | |
transaction | HIG | Common Stock | Sale | -$22.6K | -200 | -0.4% | $112.98 | 50.2K | Feb 18, 2025 | Direct | F2, F3 |
transaction | HIG | Common Stock | Sale | -$750K | -6.66K | -13.27% | $112.58 | 43.5K | Feb 18, 2025 | Direct | F2, F4 |
transaction | HIG | Common Stock | Sale | -$758K | -6.73K | -15.46% | $112.61 | 36.8K | Feb 18, 2025 | Direct | F2, F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Performance Shares | Award | $0 | +11K | $0.00 | 11K | Feb 18, 2025 | Common Stock | 11K | Direct | F1 | ||
transaction | HIG | Performance Shares | Options Exercise | $0 | -11K | -100% | $0.00 | 0 | Feb 18, 2025 | Common Stock | 11K | Direct | F1 | |
transaction | HIG | Stock Option | Options Exercise | $0 | -6.73K | -33.34% | $0.00 | 13.5K | Feb 18, 2025 | Common Stock | 6.73K | $48.89 | Direct | F6 |
transaction | HIG | Stock Option | Options Exercise | $0 | -6.86K | -50% | $0.00 | 6.86K | Feb 18, 2025 | Common Stock | 6.86K | $43.59 | Direct | F7 |
holding | HIG | Stock Option | 26.7K | Feb 18, 2025 | Common Stock | 26.7K | $49.01 | Direct | F8 | |||||
holding | HIG | Stock Option | 25.2K | Feb 18, 2025 | Common Stock | 25.2K | $51.87 | Direct | F9 | |||||
holding | HIG | Stock Option | 24.9K | Feb 18, 2025 | Common Stock | 24.9K | $53.81 | Direct | F10 | |||||
holding | HIG | Stock Option | 24.1K | Feb 18, 2025 | Common Stock | 24.1K | $55.27 | Direct | F11 | |||||
holding | HIG | Stock Option | 24.2K | Feb 18, 2025 | Common Stock | 24.2K | $69.41 | Direct | F12 | |||||
holding | HIG | Stock Option | 24.3K | Feb 18, 2025 | Common Stock | 24.3K | $78.28 | Direct | F13 | |||||
holding | HIG | Stock Option | 16.5K | Feb 18, 2025 | Common Stock | 16.5K | $95.74 | Direct | F14 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | On February 18, 2025, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2022 through December 31, 2024 performance period. The performance shares were paid in shares of the Company's common stock. |
F2 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 14, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
F3 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $112.97-$112.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F4 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $111.91-$112.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F5 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $112.10-$112.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F6 | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
F7 | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
F8 | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
F9 | The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. |
F10 | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
F11 | The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
F12 | One-third of the options became exercisable on February 23, 2023, an additional one-third of the options became exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date. |
F13 | One-third of the options became exercisable on February 28, 2024, an additional one-third of the options will become exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |
F14 | One-third of the options will become exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. |